Evelo Biosciences Inc
NASDAQ:EVLO
Evelo Biosciences Inc
Tax Provision
Evelo Biosciences Inc
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Evelo Biosciences Inc
NASDAQ:EVLO
|
Tax Provision
-$900k
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Tax Provision
-$1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-2%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Tax Provision
-$617m
|
CAGR 3-Years
28%
|
CAGR 5-Years
23%
|
CAGR 10-Years
9%
|
|
Amgen Inc
NASDAQ:AMGN
|
Tax Provision
-$582m
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Tax Provision
-$748m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-56%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Tax Provision
-$184.2m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
6%
|
See Also
What is Evelo Biosciences Inc's Tax Provision?
Tax Provision
-900k
USD
Based on the financial report for Sep 30, 2023, Evelo Biosciences Inc's Tax Provision amounts to -900k USD.
What is Evelo Biosciences Inc's Tax Provision growth rate?
Tax Provision CAGR 3Y
-29%
Over the last year, the Tax Provision growth was -84%. The average annual Tax Provision growth rates for Evelo Biosciences Inc have been -29% over the past three years .